Grifols Egypt for Plasma Derivatives (GEPD)
Nashwa Nashaat is currently serving as the Plasma Collection Operations and Medical Director at Grifols Egypt for Plasma Derivatives (GEPD). With a background in Onco-Hematology and Genetics, she also founded Nexus eHealth and holds the position of Founder. Additionally, she is the Deputy Chief Executive Officer at WeCare Foundation. Nashwa has extensive experience in the pharmaceutical industry, having held various leadership roles at companies like Johnson & Johnson, Eli Lilly and Company, and Novartis. Prior to her industry roles, she gained medical experience as a Resident Physician at the National Cancer Institute and as a Supervisor and Head of Department at the Ministry of Health and Population of Egypt. Nashwa Nashaat is a highly qualified professional with a strong background in medicine, genetics, and leadership.
This person is not in any teams
Grifols Egypt for Plasma Derivatives (GEPD)
Grifols Egypt for plasma derivatives is a joint-venture (JV) company between the Egyptian Government, through the National Service Projects Organization (NSPO) and Grifols, the global leader in plasma medicines with more than 110 years of contribution to improving the health and well-being of people. This joint venture is the first of its kind in the plasma industry and the first-ever Egyptian source member of the Plasma Protein Therapeutics Association (PPTA). GEPD is a groundbreaking global public-private alliance that will benefit the entire region. GEPD is committed to developing the plasma medicines market and achieving self-sufficiency in these critical therapies, which is crucial for the Egyptian healthcare system. We are combining the expertise of both shareholders to build and operate 20 plasma donation centers throughout Egypt, along with manufacturing facilities including fractionation, purification, and fill-and-finish plants with a processing capacity of up to 1 million liters of plasma annually that can double in the future. The new manufacturing facility will include a plasma warehouse and a testing laboratory. It will occupy 105,000 square meters strategically located in the administrative capital’s medical city, adjoining various healthcare institutions.